Binding and functional profile of KMD-3213 predicts low propensity for vascular side effects June 21, 2000
Recently issued patent covers potent and selective alpha1A-adrenoceptor antagonists from Merck June 13, 2000
AVI BioPharma and collaborators offer key findings for polycystic kidney disease drug development June 9, 2000
New compounds from Sanofi-Synthelabo preferably contract urethral smooth muscle and veins June 7, 2000
RSS